Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy response and resistance.

Soyoung Lee1, Clemens A Schmitt

  • 1Max-Delbrück-Center for Molecular Medicine and Charité/Campus, Virchow-Hospital, Department of Hematology/Oncology, Humboldt-University, D-13353 Berlin, Germany.

Current Opinion in Genetics & Development
|February 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: Interpreting P-CAB Superiority for Antithrombotic Gastroprotection Beyond Acid Suppression. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

Atrophy in preclinical Alzheimer's disease maps to a network that predicts longitudinal decline.

Molecular psychiatry·2026
Same author

Full-spectrum EEM end-member unmixing with statistical validation: A deep learning framework for organic pollution source apportionment in complex watersheds.

Journal of environmental management·2026
Same author

Evidence-Based Exploration of Exposure-Matched Candidate Pirfenidone Dose for East Asian Populations based on Population Pharmacokinetic Modeling and Simulation Approach.

Clinical therapeutics·2026
Same author

Editorial: Prevention of Upper GI Bleeding in Users of Anti-Thrombotic Drugs-P-CABs Versus PPIs. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

Correction: Cross-protective efficacy of NA-based mRNA vaccine candidates against seasonal and avian influenza viruses.

Frontiers in microbiology·2026

Cellular defense programs like apoptosis and premature senescence are crucial for preventing cancer. Defects in these pathways can lead to chemotherapy resistance in malignancies.

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Oncology

Background:

  • Apoptosis and premature senescence are key cellular defense mechanisms against oncogenic transformation.
  • These programs represent terminal cell-cycle arrest and are inducible.
  • Recent evidence highlights their role in cancer therapy response.

Purpose of the Study:

  • To investigate the role of apoptosis and premature senescence in cancer therapy.
  • To understand how defects in these cellular programs contribute to chemoresistance.

Main Methods:

  • The study reviews existing evidence on apoptosis and senescence in cancer.
  • It analyzes how oncogene activation influences cellular responses.
  • The research examines the impact of mutations on these defense mechanisms.

Related Experiment Videos

Main Results:

  • Activated oncogenes can sensitize cells to stimuli that trigger apoptosis and senescence.
  • Both apoptosis and premature senescence are responsive to cancer therapeutic drugs.
  • Mutations in malignancies can compromise these programs, leading to varied degrees of chemoresistance.

Conclusions:

  • Apoptosis and premature senescence are critical for cancer therapy outcomes.
  • Defects in these cellular defense pathways are a significant cause of chemotherapy resistance.
  • Understanding these mechanisms is vital for developing more effective cancer treatments.